Literature DB >> 29417867

Bioinformatic analyses of microRNA-targeted genes and microarray-identified genes correlated with Barrett's esophagus.

Jing Lv1,2, Jijun Liu1, Lei Guo1, Jun Zhang2, Yan Cheng2, Chu Chen1, Heping Zhao1, Jihan Wang1.   

Abstract

Barrett's esophagus (BE) is defined as a metaplasia condition in the distal esophagus, in which the native squamous epithelium lining is replaced by a columnar epithelium with or without intestinal metaplasia. It is commonly accepted that BE is a precancerous lesion for esophageal adenocarcinoma. The aim of this study was to investigate the aberrant microRNAs (miRNAs) and differentially expressed genes (DEGs) associated with BE based on online microarray datasets. One miRNA and five gene expression profiling datasets were retrieved from the Gene Expression Omnibus Database. Aberrant microRNAs and DEGs were obtained using R/Bioconductor statistical analysis language and software. 23 dysregulated miRNAs and 632 DEGs demonstrating consistent expression tendencies in the five gene microarrays were identified in BE. Moreover, 1962 target genes of aberrant miRNAs were predicted using three bioinformatic tools, namely TargetScan, RNA22-HSA and miRDB. Ultimately, 93 target DEGs were obtained, after which functional annotation was performed on DAVID Bioinformatics Resources. Among Gene Ontology (GO) biological processes, digestive tract development and epithelial cell differentiation have demonstrated significant associations with BE pathogenesis. In addition, analysis of the KEGG pathways has revealed associations with cancer. To enable further study, one miRNA-target DEGs regulatory network was constructed using Cytoscape. 6 target DEGs demonstrated higher-degree distributions in the network, and ROC analysis indicated that FNDC3B may be the best potential biomarker for BE diagnosis. The data presented herein may provide new perspectives for exploring BE pathogenesis and may offer hits with regard to potential biomarkers in BE diagnosis, prediction and therapeutic evaluation.

Entities:  

Keywords:  Barrett's esophagus; bioinformatic analyses; differentially expressed genes; microRNA; microarray

Mesh:

Substances:

Year:  2018        PMID: 29417867      PMCID: PMC5969547          DOI: 10.1080/15384101.2018.1431597

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  51 in total

1.  The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.

Authors:  Rom S Leidner; Lakshmeswari Ravi; Patrick Leahy; Yanwen Chen; Beth Bednarchik; Mirte Streppel; Marcia Canto; Jean S Wang; Anirban Maitra; Joseph Willis; Sanford D Markowitz; Jill Barnholtz-Sloan; Mark D Adams; Amitabh Chak; Kishore Guda
Journal:  Genes Chromosomes Cancer       Date:  2012-02-03       Impact factor: 5.006

2.  A microarray analysis for differential gene expression in the soybean genome using Bioconductor and R.

Authors:  W Gregory Alvord; Jean A Roayaei; Octavio A Quiñones; Katherine T Schneider
Journal:  Brief Bioinform       Date:  2007-09-29       Impact factor: 11.622

3.  MicroRNA in cancer prognosis.

Authors:  Frank J Slack; Joanne B Weidhaas
Journal:  N Engl J Med       Date:  2008-12-18       Impact factor: 91.245

Review 4.  Risk factors affecting the Barrett's metaplasia-dysplasia-neoplasia sequence.

Authors:  Craig S Brown; Michael B Ujiki
Journal:  World J Gastrointest Endosc       Date:  2015-05-16

Review 5.  Inflammation and Barrett's carcinogenesis.

Authors:  A Poehlmann; D Kuester; P Malfertheiner; T Guenther; A Roessner
Journal:  Pathol Res Pract       Date:  2012-04-27       Impact factor: 3.250

6.  MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.

Authors:  B P L Wijnhoven; D J Hussey; D I Watson; A Tsykin; C M Smith; M Z Michael
Journal:  Br J Surg       Date:  2010-06       Impact factor: 6.939

7.  ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.

Authors:  Nicholas J Shaheen; Gary W Falk; Prasad G Iyer; Lauren B Gerson
Journal:  Am J Gastroenterol       Date:  2015-11-03       Impact factor: 10.864

8.  Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals.

Authors:  Pavla Luzna; Jan Gregar; Ivo Uberall; Lenka Radova; Vlastimil Prochazka; Jiri Ehrmann
Journal:  Diagn Pathol       Date:  2011-11-17       Impact factor: 2.644

9.  Profiling of circulating microRNAs in patients with Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Pauline Bus; Christine Kestens; Fiebo Jan Willem Ten Kate; Wilbert Peters; Joost Paulus Hubertus Drenth; Jeanine Merel Leonoor Roodhart; Peter Derk Siersema; Jantine Wilhelmina Paula Maria van Baal
Journal:  J Gastroenterol       Date:  2015-11-19       Impact factor: 7.527

10.  Downregulation of ULK1 by microRNA-372 inhibits the survival of human pancreatic adenocarcinoma cells.

Authors:  Hongxi Chen; Zhipeng Zhang; Yebin Lu; Kun Song; Xiwu Liu; Fada Xia; Weijia Sun
Journal:  Cancer Sci       Date:  2017-08-10       Impact factor: 6.716

View more
  4 in total

1.  Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer.

Authors:  Jara Martín; Joan Josep Castellano; Ramón María Marrades; Jordi Canals; Nuria Viñolas; Tania Díaz; Laureano Molins; Daniel Martinez; Bing Han; Jorge Moisés; Yangyi He; Mariano Monzó; Alfons Navarro
Journal:  Transl Lung Cancer Res       Date:  2021-04

2.  HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.

Authors:  Lin Jiang; Ranran Wang; Li Fang; Xiaolu Ge; Lingna Chen; Ming Zhou; Yanhong Zhou; Wei Xiong; Yerong Hu; Xianming Tang; Guiyuan Li; Zheng Li
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

3.  Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.

Authors:  Michael P Craig; Sumudu Rajakaruna; Oleg Paliy; Mumtaz Sajjad; Srivats Madhavan; Nikhil Reddy; Jin Zhang; Michael Bottomley; Sangeeta Agrawal; Madhavi P Kadakia
Journal:  Clin Transl Gastroenterol       Date:  2020-01       Impact factor: 4.396

4.  Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.

Authors:  Haiping Zhang; Jian Zou; Ying Yin; Bo Zhang; Yaling Hu; Jingjing Wang; Huijun Mu
Journal:  PeerJ       Date:  2019-11-26       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.